Interestingly, preclinical models have suggested that ICD‐inducing therapy through pyroptosis could recruit CD8+ T cells and other lymphocytes as well as myeloid cells to the surrounding tumor lesions in the TME.47 This evidence concerns the gene CD8A and neoplasm.